CD93 and metastatic malignant neoplasm in the lymph nodes: The results suggest that the expression of ECM2, PCDH12, EPAS1, CD93, DLL4, and ARHGEF15 are significantly different in age, N (lymph node metastasis status), and whether radiotherapy is received or not (Fig. 6A).